Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phaos Technology Holdings CaymanPOAS -0.58%8 Operating Cash Flow per Share is $ as of Apr. 2026. GuruFocus rates POAS with a GF Score™ of 8/100. The stock has 8 warning signs investors should review. Among 653 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 98.93% on this metric.
Phaos Technology Holdings Cayman's operating cash flow per share for the
six
months ended in Apr. 2026 was $-0.36.
Phaos Technology Holdings Cayman does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in Apr. 2026.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -88.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Phaos Technology Holdings Cayman's Operating Cash Flow per Share or its related term are showing as below:
POAS'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -88.6 Med: -88.6 Max: -88.6
Current: -88.6
During the past 4 years, Phaos Technology Holdings Cayman's highest 3-Year average Operating Cash Flow per Share Growth Rate was -88.60% per year. The lowest was -88.60% per year. And the median was -88.60% per year.
POAS's 3-Year OCF Growth Rate is ranked worse than 98.93% of 653
companies
in the Medical Devices & Instruments industry
Industry Median: 12.8
vs POAS: -88.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman Operating Cash Flow per Share Chart
Phaos Technology Holdings Cayman Annual Data
Trend
Apr23
Apr24
Apr25
Apr26
Operating Cash Flow per Share
-0.03
-0.03
-0.07
-0.41
Phaos Technology Holdings Cayman Semi-Annual Data
Oct25
Apr26
Operating Cash Flow per Share
-0.02
-0.36
POAS vs NUWE, ADMT, CSDX: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's Price-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $ mean?
Phaos Technology Holdings Cayman (POAS) has a Operating Cash Flow per Share of $ as of Apr. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Phaos Technology Holdings Cayman and its competitors. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #646 out of 653 companies in the Medical Devices & Instruments industry, placing it in the top 98.9%.
Is Phaos Technology Holdings Cayman's Operating Cash Flow per Share too high?
Phaos Technology Holdings Cayman's current Operating Cash Flow per Share is $. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #646 out of 653 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's Operating Cash Flow per Share compare to NUWE and ADMT?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #646 out of 653 companies for Operating Cash Flow per Share. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.80, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current Operating Cash Flow per Share is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current Operating Cash Flow per Share of $. The current Operating Cash Flow per Share is $. Phaos Technology Holdings Cayman's overall GF Score™ is 8/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current Operating Cash Flow per Share is $ as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
8GF Score
Get the complete analysis for POAS
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
